Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillipp Hartmann

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Gastroenterology|April 5, 2024
Do Glucagon-like Peptide 1 Receptor Agonists Cause Postendoscopic Aspiration Pneumonia?Phillipp Hartmann
Frontiers in Physiology|May 2, 2022
Editorial: The Microbiome in Hepatobiliary and Intestinal DiseasePhillipp Hartmann
Microorganisms|June 27, 2025
Impact of Gut Microbiome on Gut Permeability in Liver and Gut DiseasesPunnag Saha, Phillipp Hartmann
Journal of Hepatology|March 8, 2016
Tiny RNA with great effects: miR-155 in alcoholic liver diseasePhillipp Hartmann, Frank Tacke
Seminars in Liver Disease|May 6, 2021
New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver DiseasePhillipp Hartmann, Bernd Schnabl
Hepatology (Baltimore, Md.)|January 10, 2023
Can a mucosal microbiota signature predict disease severity, survival, and disease recurrence in PSC?Phillipp Hartmann, Bernd Schnabl
Journal of Hepatology|December 24, 2022
Fungal infections and the fungal microbiome in hepatobiliary disordersPhillipp Hartmann, Bernd Schnabl
Biomolecules|April 30, 2025
The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic DiseasesEliane Münte, Phillipp Hartmann
Clinical Liver Disease|April 10, 2018
Risk factors for progression of and treatment options for NAFLD in childrenPhillipp Hartmann, Bernd Schnabl
Methods and Protocols|October 26, 2022
Inexpensive, Accurate, and Stable Method to Quantitate Blood Alanine Aminotransferase (ALT) LevelsPhillipp Hartmann, Bernd Schnabl
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Gastroenterology|April 5, 2024
Do Glucagon-like Peptide 1 Receptor Agonists Cause Postendoscopic Aspiration Pneumonia?Phillipp Hartmann
Frontiers in Physiology|May 2, 2022
Editorial: The Microbiome in Hepatobiliary and Intestinal DiseasePhillipp Hartmann
Microorganisms|June 27, 2025
Impact of Gut Microbiome on Gut Permeability in Liver and Gut DiseasesPunnag Saha, Phillipp Hartmann
Journal of Hepatology|March 8, 2016
Tiny RNA with great effects: miR-155 in alcoholic liver diseasePhillipp Hartmann, Frank Tacke
Seminars in Liver Disease|May 6, 2021
New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver DiseasePhillipp Hartmann, Bernd Schnabl
Hepatology (Baltimore, Md.)|January 10, 2023
Can a mucosal microbiota signature predict disease severity, survival, and disease recurrence in PSC?Phillipp Hartmann, Bernd Schnabl
Journal of Hepatology|December 24, 2022
Fungal infections and the fungal microbiome in hepatobiliary disordersPhillipp Hartmann, Bernd Schnabl
Biomolecules|April 30, 2025
The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic DiseasesEliane Münte, Phillipp Hartmann
Clinical Liver Disease|April 10, 2018
Risk factors for progression of and treatment options for NAFLD in childrenPhillipp Hartmann, Bernd Schnabl
Methods and Protocols|October 26, 2022
Inexpensive, Accurate, and Stable Method to Quantitate Blood Alanine Aminotransferase (ALT) LevelsPhillipp Hartmann, Bernd Schnabl
Pageof 7